About

Lazar Phar­ma­ceu­ti­cals is pur­su­ing the most promis­ing research leads in a ded­i­cat­ed effort to devel­op a cure for Crohn’s disease.

Crohn’s dis­ease is an inflam­ma­to­ry dis­ease of the intestines that may affect any part of the gas­troin­testi­nal tract from mouth to anus, caus­ing a wide vari­ety of symp­toms. It pri­mar­i­ly caus­es abdom­i­nal pain, diar­rhea, vom­it­ing, or weight loss, but may also cause com­pli­ca­tions out­side the gas­troin­testi­nal tract such as skin rash­es, arthri­tis, inflam­ma­tion of the eye, tired­ness, and lack of concentration.

By ana­lyz­ing unique DNA snip­pets from unre­lat­ed Crohn’s suf­fer­ers, Lazar researchers are dis­cov­er­ing sur­pris­ing com­mon­al­i­ties at the quan­tum lev­el. Evi­dence found to date is lead­ing those researchers to the­o­rize that Crohn’s dis­ease may be be the result of vibra­tional mis­align­ments in indi­vid­ual quarks. Com­pa­ny founder (and cur­rent pres­i­dent and CEO) George Lazar believes that by realign­ing vibra­tions at the quan­tum lev­el, the research team can both cure Crohn’s dis­ease and pro­vide the much sought after exper­i­men­tal evi­dence in sup­port of String Theory.